Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-18T20:33:37.575Z Has data issue: false hasContentIssue false
  • English
  • Français

Risk of Infections Associated with Improperly Reprocessed Transrectal Ultrasound–Guided Prostate Biopsy Equipment

Published online by Cambridge University Press:  02 January 2015

Fernanda Lessa ,
Sangwoo Tak ,
Shannon R. DeVader ,
Rekha Goswami ,
Mary Anderson ,
Ian Williams ,
Kathleen F. Gensheimer  and
Arjun Srinivasan
Fernanda Lessa*
Affiliation:
Division of Healthcare Quality Promotion, Atlanta, Georgia Epidemic Intelligence Service, Office of Workforce and Career Development, Atlanta, Georgia
Sangwoo Tak
Affiliation:
Epidemic Intelligence Service, Office of Workforce and Career Development, Atlanta, Georgia
Shannon R. DeVader
Affiliation:
Centers for Disease Control and Prevention (CDC), and the CDC/Council of State and Territorial Epidemiologists Applied Epidemiology Fellowship Program, Atlanta, Georgia Maine Department of Human Services, Augusta, Maine
Rekha Goswami
Affiliation:
Togus Veterans Affairs Medical Center, Augusta, Maine
Mary Anderson
Affiliation:
Togus Veterans Affairs Medical Center, Augusta, Maine
Ian Williams
Affiliation:
Division of Viral Hepatitis, Atlanta, Georgia
Kathleen F. Gensheimer
Affiliation:
Maine Department of Human Services, Augusta, Maine
Arjun Srinivasan
Affiliation:
Division of Healthcare Quality Promotion, Atlanta, Georgia
*
Centers for Disease Control and Prevention, 1600 Clifton Road, MS A-24, Atlanta, GA 30333 (flessa@cdc.gov)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

A hospital discovered a lapse in the reprocessing procedures for transrectal ultrasound-guided prostate biopsy equipment. An investigation was initiated to assess the risks of transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and bacteria during prostate biopsies.

Methods.

We offered testing for HBV, HCV, and HIV infection to patients who had undergone prostate biopsies from January 30, 2003, through January 27, 2006. We reviewed their medical records and obtained information on the reprocessing procedures that were in use at the time for the prostate biopsy equipment.

Setting.

A healthcare facility in Maine.

Results.

Of the 528 patients exposed to improperly reprocessed prostate biopsy equipment, none tested positive for HIV or HCV. Sixteen patients (3%) tested positive for past HBV infection but had no prebiopsy HBV serologic test results available (ie, transmission from improperly reprocessed biopsy equipment was possible), and 11 (2%) had evidence of postbiopsy bacterial infections. The number of cases of HBV and bacterial infections were within reported ranges for this population and were not clustered in time. Review of the reprocessing procedures in use at the time revealed that the manufacturer-recommended brushes for cleaning the reusable biopsy needle guide were never used. Brushes did not come with the equipment and had to be ordered separately.

Conclusions.

Despite the lack of evidence of pathogen transmission in this investigation, it is critical to review the manufacturer's reprocessing recommendations and to establish appropriate procedures to avert potential pathogen transmission and subsequent patient concerns. This investigation provides a better understanding of the risks associated with improperly reprocessed transrectal ultrasound prostate biopsy equipment and serves as a methodologic tool for future investigations.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 4 , April 2008 , pp. 289 - 293
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. Pseudomonas aeruginosa infections associated with transrectal ultrasound-guided prostate biopsies—Georgia, 2005. MMWR Morb Mortal Wkly Rep 2006;55:776–777.Google Scholar
2.Dominitz, JA, Boyko, EJ, Koepsell, TD, et al.Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005;41:88–96.Google Scholar
3.McQuillan, GM, Coleman, PJ, Kruszon-Moran, D, Moyer, LA, Lambert, SB, Margolis, HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89:14–18.Google Scholar
4.Backus, L, Mole, L, Chang, S, Deyton, L. The Immunology Case Registry. J Clin Epidemiol 2001;54(suppl 1):S12–S15.Google Scholar
5.Owens, DK, Sundaram, V, Lazzeroni, LC, et al.HIV testing of at risk patients in a large integrated health care system. J Gen Intern Med 2007;22:315–320.Google Scholar
6.Rodriguez, LV, Terris, MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 1998;160:2115–2120.CrossRefGoogle ScholarPubMed
7.Raaijmakers, R, Kirkels, WJ, Roobol, MJ, Wildhagen, MF, Schröder, FH. Complication rates and risk factors of 5802 transrectal-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002;60:826–830.Google Scholar
8.Rutala, WA, Gergen, MF, Weber, DJ. Disinfection of a probe used in ultrasound-guided prostate biopsy. Infect Control Hosp Epidemiol 2007;28:916–919.Google Scholar
9.Veterans Health Administration Warning System. Published by VA Central Office. April 3, 2006. Available at: http://www.va.gov/ncps/alerts/b-kmedicaltransduceralert06-011.pdf. Accessed August 21, 2007.Google Scholar
10.FDA Public Health Notification: Reprocessing of Reusable Ultrasound Transducer Assemblies Used for Biopsy Procedures. June 19,2006. Available at: http://www.fda.gov/cdrh/safety/061906-ultrasoundtransducers.html. Accessed August 21, 2007.Google Scholar
11.Gillespie, JL, Arnold, KE, Noble-Wang, J, et al.Outbreak of Pseudomonas aeruginosa infections after transrectal ultrasound-guided prostate biopsy. Urology 2007;69:912–914.Google Scholar
12.Bronowicki, JP, Venard, V, Botte, C, et al.Patient-to-patient transmission of hepatitis C virus during colonoscopy (published correction appears in N Engl J Med 2001;344:392). N Engl J Med 1997;337:237–240.Google Scholar
13.Vanhems, P, Gayet-Ageron, A, Ponchon, T, et al.Follow-up and management of patients exposed to a flawed automated endoscope washer-disinfector in a digestive diseases unit. Infect Control Hosp Epidemiol 2006;27:89–92.CrossRefGoogle Scholar
14.Morris, J, Duckworth, GJ, Ridgway, GL. Gastrointestinal endoscopy decontamination failure and the risk of transmission of blood-borne viruses: a review. J Hosp Infect 2006;63:1–13.CrossRefGoogle ScholarPubMed
15.Rutala, WA, Weber, DJ. How to assess risk of disease transmission to patients when there is a failure to follow recommended disinfection and sterilization guidelines. Infect Control Hosp Epidemiol 2007;28:146–155.CrossRefGoogle ScholarPubMed